...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara

ya,5 mil is wonderful & all but whats next? If there going to stay private & work this baby for 2-3 more years it sure would be nice if the conpany offered a fella a buy bac of sorts giving some/maybe most a chance to take a little money off the table.

Hopefully a deal is close!

 

glta 

Share
New Message
Please login to post a reply